Quick Answer
UroGen Pharma Ltd. reported Shares Outstanding of 48.35 million shares for fiscal year 2025.
UroGen Pharma Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 48.35M | +14.5% |
| 2024 | 42.23M | +30.0% |
| 2023 | 32.49M | +40.5% |
| 2022 | 23.13M | +3.0% |
| 2021 | 22.46M | +1.3% |
| 2020 | 22.17M | +5.4% |
| 2019 | 21.03M | +29.7% |
| 2018 | 16.21M | +17.9% |
| 2017 | 13.75M | +496.4% |
| 2016 | 2.31M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 46.78M | +10.9% | +1.3% |
| June 30, 2025 | 46.20M | +12.2% | +0.2% |
| March 31, 2025 | 46.10M | +27.6% | +9.2% |
| December 31, 2024 | 42.23M | +30.0% | +0.1% |
| September 30, 2024 | 42.19M | -0.0% | +2.5% |
| June 30, 2024 | 41.17M | +75.2% | +14.0% |
| March 31, 2024 | 36.13M | +54.1% | +11.2% |
| December 31, 2023 | 32.49M | +40.5% | -23.0% |
- UroGen Pharma Ltd. showed an increase of +14.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2016–2025 period, UroGen Pharma Ltd.’s shares outstanding has grown by 1996.9% (from 2.31 million shares to 48.35 million shares).
- The most recent figure is from UroGen Pharma Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: